Nordicus Partners Corp

Nord Anglia Education, Inc. engages in the operation of schools. The company was founded in 1972 and is headquartered in Hong Kong.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nordicus Partners Corp. engages in the provision of financial consulting services. The company was founded on April 7, 1993 and is headquartered in Beverly Hills, CA.

BEVERLY HILLS, California, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, today announced that its two wholly-owned subsidiaries, Orocidin A/S (“Orocidin”) and Bio-Convert ApS (“Bio-Convert”), expect to begin pilot efficacy studies in patients with periodontitis and oral leukoplakia in 2025. As of today both Orocidin and Bio-Convert are preclinical phase biopharmaceutical companies, which was incorrectly stated in previous press releases.

Orocidin and Bio-Convert expects to begin pilot efficacy studies in 2025

BEVERLY HILLS, California, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, today announced FINRA has removed the appending "D" to the root symbol of its OTC equity symbol after the 20-day transition period subject to its reverse split with a CUSIP change announced on November 7, 2024.

NORDICUS now trading under symbol NORD

Beverly Hills, California., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, today announced it has entered into an agreement with Orocidin A/S (“Orocidin”) to acquire the remaining approximately 5% of its outstanding shares for 200,000 of the Company's restricted common shares in an all stock-transaction to the selling shareholders.

Nordicus Partners Corporation Acquires the Remaining 5% Shares In Orocidin A/S

Beverly Hills, California., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, today announced that it entered into an agreement with Bio-Convert ApS (“Bio-Convert”) to acquire 100% of its shares outstanding in Bio-Convert for 12 million of the Company's restricted common shares in an all-stock transaction to the selling shareholders.

Nordicus Partners Corporation Acquires Bio-Convert ApS

Beverly Hills, California., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, today announced that it will effect a 1-for-10 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.001per share (“Common Stock”), that will become effective at 12:01 a.m. Eastern Time on November 8, 2024. The Company's Common Stock will continue to trade on the OTCQB market under the symbol “NORD” and will begin trading on a split-adjusted basis when the OTC market opens on November 8, 2024.

Nordicus Partners Corporation Announces Reverse Stock Split

Beverly Hills, California., July 03, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves in the U.S. market, today announced it will host a webinar for existing and prospective investors on Wednesday, July 10, 2024, at 9:00 AM Pacific time / 12:00 PM Eastern time / 6:00 PM CET.

Nordicus Partners To Host Investor Relations Webinar on July 10, 2024

Beverly Hills, California., June 21, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, today announced it entered into a Consultancy Agreement with BIO-CONVERT in Denmark.

Nordicus Partners Corporation Enters Into A Consultancy Agreement With BIO-CONVERT In Denmark

Beverly Hills, California., June 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, and its 95% owned subsidiary, Orocidin A/S (“Orocidin”), announced today new insights into the treatment of periodontitis.

Orocidin – New Insights Into The Treatment Of Periodontitis

Beverly Hills, California, June 04, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, announced today the appointment of Peter Severin as Chairman of the Board of Directors. Peter Severin replaces Christian Hill-Madsen as Chairman, who resigned to focus on developing the next generation of periodontities therapies for Orocidin A/S, a company owned 95% by Nordicus, where Christian currently serves as Chairman of its Board.

Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors

Beverly Hills, California., May 23, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, announced on the 15th of May, 2024 the acquisition of a 95% stake in Orocidin A/S (“Orocidin”) and announced today that it has engaged investor awareness specialists, FORCE Family Office (“FORCE”). Representing the world's largest community of Family Offices, Foundations, and Endowments, FORCE will be sharing Nordicus' and Orocidin's story with this community in upcoming webinars along with other events and activities.

Nordicus Partners Corporation Engages FORCE Family Office

Beverly Hills, California., May 15, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, announced today that it has entered into an agreement with Orocidin A/S (“Orocidin”) to acquire a 95% stake from eleven of Orocidin's shareholders for $38,000,000. Nordicus will be issuing 38 million restricted common shares in an all-stock transaction to the selling shareholders.

Nordicus Partners Corporation Acquires 95% Stake in Orocidin A/S

Beverly Hills, California., May 09, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, today announced that it has uplisted to the OTCQB. OTCQB is recognized by the SEC as an established public securities market. OTCQB companies must provide current company financial information/news and meet financial standards that enable brokers to more easily quote and trade a security.

Nordicus Partners Corporation Uplists to OTCQB

Beverly Hills, California., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTC PINK: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, today announced it entered into a paying Consultancy Agreement with Orocidin A/S in Denmark.

NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK

Las Vegas, Nevada., June 21, 2023 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTC PINK: NORD) (“Nordicus” or the “Company”), a financial consulting company, specializing in providing Nordic and U.S. companies with the best possible conditions to establish themselves on the U.S. market, today announced it entered into a Stock Purchase and Sale Agreement (the “Agreement”), under which a private seller sold to the Company 5,000,000 restricted shares of common stock of Mag Mile Capital, Inc. (“MYSN” or the “Myson Shares”). In exchange, the Company issued 2,500,000 restricted shares at $1.00 per share of its common stock (the “Company Shares”) to the seller. The transaction was consummated on June 20, 2023.

NORDICUS PARTNERS CORPORATION TAKES A SIGNIFICANT EQUITY STAKE IN MAG MILE CAPITAL, INC.

Las Vegas, Nevada., May 22, 2023 (GLOBE NEWSWIRE) -- EKIMAS Corporation (OTC PINK: NORD ) (“EKIMAS” or the “Company”), a financial consulting company specializing in providing Nordic companies with the best possible conditions to establish themselves on the U.S. market, today announced that its common stock began trading under the symbol ‘NORD' on May 17, 2023 and changed its name to Nordicus Partners Corporation. The new ticker symbol aligns with the Company's rebranding to Nordicus.

News for Nordicus Partners Corp Stock (NORD)